Combined treatment of patients with acute muscular tonic syndrome with dorsopathy

Patients who received NSAIDs, Traumeel S and Spascupreel had statistically significantly faster pain relief (VAS) on days 7 and 14 and increased volume of daily activity (RMQ) compared to standard therapy. There was also a statistically significant lower number of relapses on the day 60 from the beginning of the study and a statistically significant lower number of cases of NSAID on demand additional intake during 60 days from the beginning of the study than in the standard therapy group (NSAIDs and myorelaxants). The use of Traumeel S and Spascupreel did not cause significant AEs and drug interactions.